Literature DB >> 1485605

Congenital dyserythropoietic anemia type II diagnosed in a 69-year-old patient with iron overload.

T C Greiner1, C P Burns, F R Dick, K M Henry, I Mahmood.   

Abstract

Congenital dyserythropoietic anemia type II is a rare disorder that is often diagnosed in patients before age 20 years. Patients with this disorder, which is also called hereditary erythroblastic multinuclearity associated with a positive acidified serum lysis test, may have symptoms of iron overload. The purpose of this case report is to alert physicians to consider the diagnosis of congenital dyserythropoietic anemia type II in elderly patients who have anemia and iron overload.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485605     DOI: 10.1093/ajcp/98.5.522

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

2.  Congenital dyserythropoietic anaemia type II: a rare entity.

Authors:  Kiran Alam; Mehar Aziz; Manoranjan Varshney; Veena Maheshwari; Mahfooz Basha; Kavita Gaur
Journal:  BMJ Case Rep       Date:  2011-04-19

3.  Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.

Authors:  Hisanori Fujino; Sayoko Doisaki; Young-Dong Park; Asahito Hama; Hideki Muramatsu; Seiji Kojima; Shinichi Sumimoto
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

Review 4.  A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis.

Authors:  Themistoklis Vassiliadis; Vassilia Garipidou; Vassilios Perifanis; Konstantinos Tziomalos; Olga Giouleme; Kalliopi Patsiaoura; Michalis Avramidis; Nikolaos Nikolaidis; Sofia Vakalopoulou; Ioannis Tsitouridis; Antonios Antoniadis; Panagiotis Semertzidis; Anna Kioumi; Evangelos Premetis; Nikolaos Eugenidis
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.